<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=Fibroblast+Growth+Factors%2Fdrug+effects%2F%2Aphysiology&amp;output=omeka-xml" accessDate="2026-03-06T18:05:10-05:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="3007" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="37123">
              <text>&lt;a href="http://doi.org/10.1002/hep.22627" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/10.1002/hep.22627&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="37125">
              <text>297–305</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="37126">
              <text>1</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="37127">
              <text>49</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="37115">
                <text>Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="37116">
                <text>Hepatology (Baltimore, Md.)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="37117">
                <text>2009</text>
              </elementText>
              <elementText elementTextId="37118">
                <text>2009-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="37119">
                <text>Butadienes/pharmacology; Carcinoma; Cell Line; Chenodeoxycholic Acid/*pharmacology; Cholesterol 7-alpha-Hydroxylase/*biosynthesis; Cytoplasmic and Nuclear/metabolism/physiology; DNA-Binding Proteins/metabolism; Fibroblast Growth Factor; Fibroblast Growth Factors/drug effects/*physiology; Gene Expression/drug effects; Hepatocellular/metabolism; Hepatocytes/metabolism; Humans; Isoxazoles/pharmacology; Mitogen-Activated Protein Kinase 1/metabolism; Mitogen-Activated Protein Kinase 3/metabolism; Nitriles/pharmacology; Receptor; Receptors; Signal Transduction/drug effects; Transcription Factors/metabolism; Tumor; Type 4/antagonists &amp; inhibitors</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="37120">
                <text>Song Kwang-Hoon; Li Tiangang; Owsley Erika; Strom Stephen; Chiang John Y L</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="37121">
                <text>UNLABELLED: Mouse fibroblast growth factor 15 (FGF15) and human ortholog FGF19 have been identified as the bile acid-induced intestinal factors that mediate bile acid feedback inhibition of cholesterol 7alpha-hydroxylase gene (C YP7A1) transcription in mouse liver. The mechanism underlying FGF15/FGF19 inhibition of bile acid synthesis in hepatocytes remains unclear. Chenodeoxycholic acid (CDCA) and the farnesoid X receptor (FXR)-specific agonist GW4064 strongly induced FGF19 but inhibited CYP7A1 messenger RNA (mRNA) levels in primary human hepatocytes. FGF19 strongly and rapidly repressed CYP7A1 but not small heterodimer partner (SHP) mRNA levels. Kinase inhibition and phosphorylation assays revealed that the mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 (MAPK/Erk1/2) pathway played a major role in mediating FGF19 inhibition of CYP7A1. However, small interfering RNA (siRNA) knockdown of SHP did not affect FGF19 inhibition of CYP7A1. Interestingly, CDCA stimulated tyrosine phosphorylation of the FGF receptor 4 (FGFR4) in hepatocytes. FGF19 antibody and siRNA specific to FGFR4 abrogated GW4064 inhibition of CYP7A1. These results suggest that bile acid-activated FXR is able to induce FGF19 in hepatocytes to inhibit CYP7A1 by an autocrine/paracrine mechanism. CONCLUSION: The hepatic FGF19/FGFR4/Erk1/2 pathway may inhibit CYP7A1 independent of SHP. In addition to inducing FGF19 in the intestine, bile acids in hepatocytes may activate the liver FGF19/FGFR4 signaling pathway to inhibit bile acid synthesis and prevent accumulation of toxic bile acid in human livers.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="37122">
                <text>&lt;a href="http://doi.org/10.1002/hep.22627" target="_blank" rel="noreferrer noopener"&gt;10.1002/hep.22627&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="37124">
                <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="54">
        <name>2009</name>
      </tag>
      <tag tagId="1409">
        <name>Butadienes/pharmacology</name>
      </tag>
      <tag tagId="96">
        <name>Carcinoma</name>
      </tag>
      <tag tagId="1410">
        <name>Cell Line</name>
      </tag>
      <tag tagId="21582">
        <name>Chenodeoxycholic Acid/*pharmacology</name>
      </tag>
      <tag tagId="1299">
        <name>Chiang John Y L</name>
      </tag>
      <tag tagId="21579">
        <name>Cholesterol 7-alpha-Hydroxylase/*biosynthesis</name>
      </tag>
      <tag tagId="1411">
        <name>Cytoplasmic and Nuclear/metabolism/physiology</name>
      </tag>
      <tag tagId="32956">
        <name>Department of Integrative Medical Sciences</name>
      </tag>
      <tag tagId="1412">
        <name>DNA-Binding Proteins/metabolism</name>
      </tag>
      <tag tagId="1413">
        <name>Fibroblast Growth Factor</name>
      </tag>
      <tag tagId="21583">
        <name>Fibroblast Growth Factors/drug effects/*physiology</name>
      </tag>
      <tag tagId="1415">
        <name>Gene Expression/drug effects</name>
      </tag>
      <tag tagId="1416">
        <name>Hepatocellular/metabolism</name>
      </tag>
      <tag tagId="1405">
        <name>Hepatocytes/metabolism</name>
      </tag>
      <tag tagId="1373">
        <name>Hepatology (Baltimore, Md.)</name>
      </tag>
      <tag tagId="8">
        <name>Humans</name>
      </tag>
      <tag tagId="1417">
        <name>Isoxazoles/pharmacology</name>
      </tag>
      <tag tagId="1401">
        <name>Li Tiangang</name>
      </tag>
      <tag tagId="1418">
        <name>Mitogen-Activated Protein Kinase 1/metabolism</name>
      </tag>
      <tag tagId="1419">
        <name>Mitogen-Activated Protein Kinase 3/metabolism</name>
      </tag>
      <tag tagId="32953">
        <name>NEOMED College of Medicine</name>
      </tag>
      <tag tagId="1420">
        <name>Nitriles/pharmacology</name>
      </tag>
      <tag tagId="1425">
        <name>Owsley Erika</name>
      </tag>
      <tag tagId="863">
        <name>Receptor</name>
      </tag>
      <tag tagId="551">
        <name>Receptors</name>
      </tag>
      <tag tagId="1421">
        <name>Signal Transduction/drug effects</name>
      </tag>
      <tag tagId="1389">
        <name>Song Kwang-Hoon</name>
      </tag>
      <tag tagId="1408">
        <name>Strom Stephen</name>
      </tag>
      <tag tagId="1422">
        <name>Transcription Factors/metabolism</name>
      </tag>
      <tag tagId="1423">
        <name>Tumor</name>
      </tag>
      <tag tagId="1424">
        <name>Type 4/antagonists &amp; inhibitors</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
